FDA & Internet: Lessons & Scenarios for Biopharma Communicators
This panel, moderated by David Maizenberg, will feature former Division Director at FDA and 30 year biopharma veteran, Max Talbott, Joanna Napp, Healthcare and IP partner at Jackson Walker, and health care law expert Jeffery Drummond. The discussion will cover FDA regulation of Internet-based communications by biopharmaceutical companies, starting with the recent keyword advertising warning letters and subsequent draft regulations. The panel will also delve into possible scenarios for biopharmaceutical company participation in conversational and social media: the next frontier for communications with doctors, patients and wider communities of interest.
- Presenting
- Max Talbott, FDA; Joanna Napp, Jackson Walker; Jeffery Drummond, Jackson Walker
- Channel
- Medicine and Healthcare
- Date
- Jul 23 2009
- Duration
- 3594
- Tags
- Social, Media, Biopharmaceutical, FDA, Regulation
Flash is required to view this webcast/channel:
You need version 9.0.115.0 or later of the free Flash player from Adobe
to use this content.
To download and install the free player from Adobe's web site
click here.
